Literature DB >> 13197736

The effects of isoniazid on patients with multiple sclerosis; preliminary report.

J F KURTZKE, L BERLIN.   

Abstract

Entities:  

Keywords:  MULTIPLE SCLEROSIS/therapy; NICOTINIC ACID ISOMERS/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13197736     DOI： 10.1164/art.1954.70.4.577

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  7 in total

1.  Disseminated sclerosis treated with isoniazid with a method of evaluating chronic neurological disorders.

Authors:  B M ANSELL; E CLARKE
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-05       Impact factor: 10.154

2.  [Pathogenesis of demyelinating encephalomyelitis (including acute multiple sclerosis) and polyneuritis].

Authors:  E PETTE; H PETTE
Journal:  Klin Wochenschr       Date:  1956-07-15

3.  Pellagra caused by isoniazid.

Authors:  M FEIWEL; R J HARRISON
Journal:  Br Med J       Date:  1956-10-13

4.  Failure in treatment of multiple sclerosis patients with isoniazid.

Authors:  A DEKABAN
Journal:  Can Med Assoc J       Date:  1955-09-15       Impact factor: 8.262

5.  The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson.

Authors:  Eric J Kildebeck; Ram Narayan; Avindra Nath; Howard Weiner; Shin Beh; Peter A Calabresi; Lawrence Steinman; Eugene O Major; Teresa C Frohman; Elliot M Frohman
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

Review 6.  What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.

Authors:  Bilge Piri Çinar; Yüksel Güven Yorgun
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

7.  A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.

Authors:  C B Bozek; L F Kastrukoff; J M Wright; T L Perry; T A Larsen
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.